Banque Pictet & Cie’s Arcellx ACLX Stock Holding History

Banque Pictet & Cie’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,109	Closed	-$333K	–	386
2025 Q4	$333K	Buy	+5,109	New	+$408K	﹤0.01%	348

Other funds holding ACLX

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Fidelity International

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Banque Pictet & Cie's ACLX Position: Q1 2026 in Review

Banque Pictet & Cie sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 5,109 shares — an estimated $333K sold.

Banque Pictet & Cie first reported a position in ACLX in Q4 2025 and held it in 1 quarter. The position peaked at $333K in Q4 2025. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

Banque Pictet & Cie reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
Banque Pictet & Cie sold 5,109 Arcellx shares in Q1 2026, an estimated $333K.
Banque Pictet & Cie first reported a position in Arcellx in Q4 2025 and held it in 1 quarter.
Banque Pictet & Cie's Arcellx position peaked at $333K in Q4 2025.
239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.